Reaction equation
Cl[C:2]1[N:3]=[C:4]([NH:11][C@H:12]([CH:16]([CH3:18])[CH3:17])[C:13]([NH2:15])=[O:14])[C:5]2[S:10][CH2:9][CH2:8][C:6]=2[N:7]=1.[Cl:19][C:20]1[CH:25]=[CH:24][C:23]([N:26]2[CH2:31][CH2:30][NH:29][CH2:28][CH2:27]2)=[CH:22][CH:21]=1.C(N(C(C)C)CC)(C)C.O>O1CCOCC1>[Cl:19][C:20]1[CH:21]=[CH:22][C:23]([N:26]2[CH2:31][CH2:30][N:29]([C:2]3[N:3]=[C:4]([NH:11][C@H:12]([CH:16]([CH3:18])[CH3:17])[C:13]([NH2:15])=[O:14])[C:5]4[S:10][CH2:9][CH2:8][C:6]=4[N:7]=3)[CH2:28][CH2:27]2)=[CH:24][CH:25]=1Participants
6
Reactant 4
Product 1
Reagents, catalysts & solvents 1
Conditions
- Temperature
- 160 °C
Procedure
400 mg (R)-2-(2-chloro-6,7-dihydro-thieno[3,2-d]pyrimidin-4-ylamino)-3-methyl-butyramide, 750 mg 1-(4-chloro-phenyl)-piperazine and 1.2 ml diisopropylethylamine are placed in 9 ml dioxane, then heated in the microwave for 1 hour and 45 minutes at 160° C. Then water is added. The precipitate formed is suction filtered and dried. 550 mg of the product are obtained as a powder. Analytical HPLC (method B): RT=3.03 min.
Workup
- customThe precipitate formed
- filtrationfiltered
- customdried
Sources & evidence
- ORD record
- ord-f1f6c059d996401f91be22d95e1c3696
- Source dataset
- uspto-grants-2014_09
- Patent number
- US08822474B2
Linked notes
Loading…